These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34518964)

  • 21. Different B-cell populations are responsible for the peripheral and intrathecal antibody production in neuroborreliosis.
    Lakos A; Ferenczi E; Komoly S; Granström M
    Int Immunol; 2005 Dec; 17(12):1631-7. PubMed ID: 16303786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study on the role of CXCL13 in Lyme neuroborreliosis.
    Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA
    Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal Th17- and B cell-associated cytokine and chemokine responses in relation to clinical outcome in Lyme neuroborreliosis: a large retrospective study.
    Gyllemark P; Forsberg P; Ernerudh J; Henningsson AJ
    J Neuroinflammation; 2017 Feb; 14(1):27. PubMed ID: 28148307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroimmunomodulators in Neuroborreliosis and Lyme Encephalopathy.
    Eckman EA; Pacheco-Quinto J; Herdt AR; Halperin JJ
    Clin Infect Dis; 2018 Jun; 67(1):80-88. PubMed ID: 29340592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
    Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections.
    Pícha D; Moravcová L; Smíšková D
    J Neurol Sci; 2016 Sep; 368():214-20. PubMed ID: 27538636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U; Mygland A
    J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.
    Cerar T; Ogrinc K; Lotric-Furlan S; Kobal J; Levicnik-Stezinar S; Strle F; Ruzić-Sabljic E
    Clin Vaccine Immunol; 2013 Oct; 20(10):1578-84. PubMed ID: 23945160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis.
    Eckman EA; Clausen DM; Herdt AR; Pacheco-Quinto J; Halperin JJ
    Clin Infect Dis; 2021 May; 72(10):1719-1726. PubMed ID: 32221538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed diagnosis of lyme neuroborreliosis presenting with abducens neuropathy without intrathecal synthesis of Borrelia antibodies.
    Radzišauskienė D; Ambrozaitis A; Marciuškienė E
    Medicina (Kaunas); 2013; 49(2):89-94. PubMed ID: 23888345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody responses to immunoevasion proteins BBK32 and OspE constitute part of the serological footprint in neuroborreliosis but are insufficient to prevent the disease.
    Dulipati V; Kotimaa J; Rezola M; Kontiainen M; Jarva H; Nyman D; Meri S
    Scand J Immunol; 2024 Apr; 99(4):e13353. PubMed ID: 39007994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32, and OspC, and VlsE IR6 peptide.
    Panelius J; Lahdenne P; Saxén H; Carlsson SA; Heikkilä T; Peltomaa M; Lauhio A; Seppälä I
    J Neurol; 2003 Nov; 250(11):1318-27. PubMed ID: 14648148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
    Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.
    Marangoni A; Sparacino M; Mondardini V; Cavrini F; Storni E; Donati M; Cevenini R; Sambri V
    New Microbiol; 2005 Jan; 28(1):37-43. PubMed ID: 15782625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lyme neuroborreliosis with antibodies in cerebrospinal fluid but not in serum.
    Zomer TP; Bruinsma R; van Samkar A; Vermeeren YM; Wieberdink RG; van Kooten B; van Bemmel T
    Eur J Neurol; 2023 Mar; 30(3):741-744. PubMed ID: 36371644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to recombinant decorin-binding proteins A and B in the cerebrospinal fluid of patients with Lyme neuroborreliosis.
    Panelius J; Sillanpää H; Seppälä I; Sarvas H; Lahdenne P
    Scand J Infect Dis; 2007; 39(9):775-80. PubMed ID: 17701715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays.
    Henningsson AJ; Christiansson M; Tjernberg I; Löfgren S; Matussek A
    Eur J Clin Microbiol Infect Dis; 2014 May; 33(5):797-803. PubMed ID: 24263552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consequences of the Edge Effect in a Commercial Enzyme-Linked Immunosorbent Assay for the Diagnosis of Lyme Neuroborreliosis.
    van Gorkom T; van Arkel GHJ; Voet W; Thijsen SFT; Kremer K
    J Clin Microbiol; 2021 Jul; 59(8):e0328020. PubMed ID: 33980651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Competitive inhibition ELISA for the detection of Borrelia burgdorferi antigens--failure to detect antigen in the cerebrospinal fluid from patients with neuroborreliosis.
    Rauer S; Conrad A
    J Med Microbiol; 2001 Jun; 50(6):577-8. PubMed ID: 11393297
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
    Gudowska-Sawczuk M; Mroczko B
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.